Article
Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19
11 Nov 2022
Abstract excerpt
Vitamin D deficiency is associated with a higher risk of SARS-CoV-2 infection and poor outcomes of the COVID-19 disease. However, a satisfactory mechanism explaining the vitamin D protective effects is missing. Based on the anti-inflammatory and anti-oxidative properties of classical and novel (CYP11A1-derived) vitamin D and lumisterol hydroxymetabolites, we have proposed that they would attenuate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
